Strides Arcolab Q2 net profit rises to Rs 19 crore

NEW DELHI: Drug firm Strides Arcolab today reported a consolidated net profit of Rs 18.97 crore for the quarter ended September 30, 2015.

The company had posted a net loss of Rs 42.55 crore from the continuing operations for June-September quarter of the previous fiscal, Strides Arcolab said in a filing to BSE.

Consolidated total income of the company rose to Rs 370 crore for the quarter under review. It was Rs 286.97 crore for the same period year ago.

"It has been a strong comeback quarter for the company after a subdued first quarter with growth across businesses," Strides Arcolab Founder and Group CEO Arun Kumar said.

The performance during the quarter was further bolstered by a quick closure and integration of the acquired Arrow Pharmaceuticals business in Australia, he added.

Shares of Strides Arcolab today closed at Rs 1,287.75 per scrip on BSE, down 2.25 per cent from the previous close.